om24: Research

OM24^® is an innovation of Omnimedica AG.

Omnimedica AG is a spin-off company of the ETH of Zurich and specialises in research and development of all-natural active substances.

Cell biology and clinical studies are carried out in collaboration with the ETH of Zurich, the University Hospital of Zurich, and other institutions.

Omnimedica AG operates a GMP-certified analysis laboratory. All products are developed, produced and proofed to GMP standards.